Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Expert Rev Hematol. 2023 Mar;16(sup1):71–86. doi: 10.1080/17474086.2023.2175660

Table 3.

Examples of potential collaborators in efforts to overcome barriers to important research to advance the health of people who have or had the potential to menstruate with inherited bleeding disorders

American College of Obstetricians and Gynecologists (ACOG)
American Thrombosis and Hemostasis Network (ATHN)
Centers for Disease Control and Prevention (CDC) Office of Women’s Health and Division of Blood Disorders
Contraceptive Clinical Trials Network (CCTN)
Fenway Institute
Foundation for Women and Girls with Blood Disorders (FWGBD)
Hemophilia Federation of America (HFA)
Hemostasis and Thrombosis Research Society (HTRS)
International Federation of Gynecology and Obstetrics (FIGO) Committee for Menstrual Disorders
International Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee (SSC) Subcommittee on Women’s Health Issues in Thrombosis and Haemostasis
Maternal Fetal Medicine Units Network (MFMU)
National Hemophilia Foundation (NHF)
National Institutes of Health (NIH): Office of Research on Women’s Health (ORWH)
Obstetric Fetal Pharmacology Research Network
Partners in Bleeding Disorders Education
PRIDEnet
World Federation of Hemophilia (WFH)
World Professional Association for Transgender Health (WPATH)